Clinical Studies Have Begun to Study the Effects of the HairMax LaserComb in Females with Hereditary Hair Loss at Five Research Sites Accross the United States

Lexington International, LLC, manufacturer of the HairMax LaserComb®, is pleased to announce the commencement of a major multi-center clinical study on the treatment of Androgenetic Alopecia (pattern baldness) in females with the HairMax LaserComb.

These new clinical studies are designed to measure the safety and efficacy of the HairMax LaserComb in females with certain classes of Androgenetic Alopecia. The studies have IRB approval and will be conducted in a double-blind and placebo controlled manner in accordance with Good Clinical Practices.

Enrollment commenced in October 2009 at 5 research centers around the country. Patients interested in participating in the trial may find further information at the NIH clinical trials registry, www.clinicaltrials.gov.

LAS